FIELD: chemistry.
SUBSTANCE: invention relates to a spiroheterocyclic compound of formula (I):
,
where: p equals 1-4; j and k are each independently equal to 0, 1, 2 or 3; Q denotes -O-, denotes a condensed 5-member heteroaryl ring with one S atom or a 6-member heteroaryl ring with one N atom; R1 denotes C1-8alkyl; each R2 independently denotes H, C1-8alkyl; each R3a, R3b R3c and R3d independently denotes H, C1-8alkyl, or R3a and R3b, or R3b and R3c, or R3c and R3d, together with carbocycle atoms to which they are directly bonded, can form a condensed dioxolyl ring, and the remaining group R3a, R3b R3c or R3d is as described above; or a pharmaceutically acceptable salt thereof.
EFFECT: compounds can be used to treat sodium channel-mediated diseases or conditions such as pain.
13 cl, 4 dwg, 2 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
SPIROOXYINDOLE DERIVATIVES AND APPLICATION THEREOF AS THERAPEUTIC AGENTS | 2006 |
|
RU2415143C2 |
NOVEL PYRAZOLOPYRIMIDINES AS INHIBITORS OF CYCLIN-DEPENDANT KINASE | 2003 |
|
RU2380369C9 |
Axl INHIBITORS APPLICABLE IN COMBINATION THERAPY FOR PREVENTING, RELIEVING OR TREATING METASTATIC CANCER | 2010 |
|
RU2555326C2 |
SHIP1 MODULATORS AND METHODS RELATED THERETO | 2014 |
|
RU2679805C2 |
TOFA ANALOGUES, APPLICABLE IN TREATMENT OF DERMATOLOGICAL DISORDERS OR CONDITIONS | 2010 |
|
RU2561729C2 |
AMINOPIPERIDINE DERIVATIVES AS CETP INACTIVATORS (CHOLESTEROL ESTER TRANSFER PROTEIN) | 2007 |
|
RU2442782C2 |
PYRROLE DERIVATIVES AS MEDICINAL SUBSTANCES | 2005 |
|
RU2470916C2 |
DERIVATIVES OF ORTHO-ANTRANILAMIDE AS ANTI-COAGULATING AGENTS, PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT | 1998 |
|
RU2226529C2 |
3,4-DISUBSTITUTED CYCLOBUTENE-1,2-DIONES AS LIGANDS OF CXC-CHEMOKINE RECEPTOR | 2002 |
|
RU2344123C9 |
TYPE 1 DIACYLGLYCEROL-O-ACYLTRANSFERASE ENZYME INHIBITORS | 2008 |
|
RU2486186C2 |
Authors
Dates
2011-09-10—Published
2006-04-11—Filed